The present invention relates to methods and kits for determining a
predisposition for developing cancer, e.g., prostate and/or breast
cancer, due to a germline mutation of a NBS1 gene. The present invention
also relates to surveillance protocols for developing cancer, e.g.,
prostate and/or breast cancer, due to germline mutation of a NBS1 gene.